Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr KM, Lantuejoul S, Noguchi M, Papotti M, Rekhtman N, Scagliotti G, van Schil P, Sholl L, Yatabe Y, Yoshida A, Travis WD (2022) The 2021 WHO classification of lung tumors: impact of advances Since 2015. J Thorac Oncol 17(3):362–387. https://doi.org/10.1016/j.jtho.2021.11.003
2. Rindi G, Moch H, McCluggage WG, et al (2022) Neuroendocrine neoplasms, non-endocrine organs. In: WHO Classification of Tumours Editorial Board, editor. WHO classification of tumours endocrine and neuroendocrine tumours. 5th ed. Lyon, France: International Agency for Research on Cancer (IARC)
3. Filosso PL, Rena O, Donati G, Casadio C, Ruffini E, Papalia E et al (2002) Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg 123(2):303–309
4. Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T et al (2019) Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. Nat Commun 10(1):3407
5. Abdel-Rahman O (2018) Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system. Clin Transl Oncol 20(5):670–677
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献